Tool Create startup animated videos in minutes, not in hours! 

Belgian medtech startup Antelope gets €9 million to develop at-home testing device for STIs

Antelope Dx, a Ghent-based company developing a palm-sized diagnostic device for home testing, has received €9 million in Series B funding to start clinical stages of a test for certain sexually-transmitted diseases. The round’s investments were split down the middle between Whitefund and existing investors that participated in a €5.1 million Series A one year ago. Specifically, the device is a urine-based test for Chlamydia trachomatis and Neisseria gonorrhea. The team is also developing tests for respiratory Influenza A/B and Sars-CoV-2, which people can do at home using a single swab sample. The startup, which is built on ten years of research at the Photonics Research Group of Ghent University and spun out from Belgian biotech company MyCartis last summer, has also raised several million in grants from the Flanders Agency for Innovation and Entrepreneurship (VLAIO).

Startup Around is now on Telegram and Whatsapp. For the best startup stories & resources, subscribe us on Telegram & Whatsapp.
Get the best stories from Startup Around on Telegram